Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · IEX Real-Time Price · USD
2.365
-0.015 (-0.63%)
At close: Jul 19, 2024, 4:00 PM
2.350
-0.015 (-0.63%)
Pre-market: Jul 20, 2024, 9:28 AM EDT
Xeris Biopharma Holdings Market Cap
Xeris Biopharma Holdings has a market cap or net worth of $350.63 million as of July 22, 2024. Its market cap has increased by 5.96% in one year.
Market Cap
350.63M
Enterprise Value
531.97M
1-Year Change
5.96%
Ranking
Category
Stock Price
$2.37
Market Cap Chart
Since June 21, 2018, Xeris Biopharma Holdings's market cap has decreased from $384.90M to $350.63M, a decrease of -8.90%. That is a compound annual growth rate of -1.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 350.60M | 8.01% |
| Dec 29, 2023 | 324.60M | 79.44% |
| Dec 30, 2022 | 180.90M | -50.49% |
| Dec 31, 2021 | 365.40M | 51.62% |
| Dec 31, 2020 | 241.00M | 26.64% |
| Dec 31, 2019 | 190.30M | -46.35% |
| Dec 31, 2018 | 354.70M | -7.85% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TScan Therapeutics | 365.81M |
| Talkspace | 358.04M |
| Vanda Pharmaceuticals | 355.59M |
| Cartesian Therapeutics | 354.90M |
| Q32 Bio | 351.81M |
| AC Immune | 345.21M |
| Cabaletta Bio | 342.28M |
| ModivCare | 335.24M |